Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients

Bone Marrow Transplantation volume 36, pages 885–889 (2005)Cite this article

Summary:

In this prospective study, we assessed the incidence of central venous catheter (CVC)-related thrombosis in haematopoietic stem cell transplant (HSCT) recipients. We determined the contribution of inherited prothrombotic abnormalities in blood coagulation to CVC-related thrombosis in these patients. The study was conducted between May 2002 and September 2004. CVCs were externalized, nontunneled, polyurethane double lumen catheters. Before catheter insertion, laboratory prothrombotic markers included factor V Leiden, the prothrombin gene Gly20210A mutation, plasma antithrombin levels, and protein C and S activity. All patients were systematically examined by ultrasonography just before, or <24 h after, catheter removal, and in case of clinical signs of thrombosis. A total of 171 patients were included during the 28-month study period. Five (2.9%) and three (1.7%) patients had evidence of protein C and protein S deficiency, respectively. Only one patient had an antithrombin deficiency (0.6%). In total, 10 patients (5.8%) were heterozygous for the factor V Leiden mutation, and one patient had heterezygous prothrombin G20210A mutation (0.6%). We observed a CVC-related thrombosis in 13 patients (7.6%). Thrombosis was diagnosed in four out of 20 patients (20%) with a inherited prothrombotic abnormality compared to nine of 151 patients (6%) who did not have a thrombophilic marker (relative risk 3.3 CI 95% 1.1–9.9). Our results suggest that inherited prothrombotic abnormalities contribute substantially to CVC-related thrombosis in HSCT recipients. In view of physicians’ reluctance to prescribe prophylactic anticoagulant treatment in these patients, a priori determination of inherited prothrombotic abnormalities may form a basis to guide these treatment decisions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Madero L, Ruano D, Villa M et al. Non-tunnelled catheters in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 17: 87–89.

    CAS  Google Scholar 

  2. Kumagai T, Sakamaki H, Tanikawa S et al. Utility and safety of Hickman catheters for venous access after bone marrow transplantation. Intern Med 1998; 37: 286–291.

    Article  CAS  Google Scholar 

  3. Male C, Chait P, Andrew M et al. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003; 101: 4273–4278.

    Article  CAS  Google Scholar 

  4. McGee DC, Gould MK . Preventing complications of central venous catheterization. N Engl J Med 2003; 348: 1123–1133.

    Article  Google Scholar 

  5. Monreal M, Raventos A, Lerma R et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines – a prospective study. Thromb Haemost 1994; 72: 548–550.

    CAS  PubMed  Google Scholar 

  6. Ross AH, Griffith CD, Anderson JR, Grieve DC . Thromboembolic complications with silicone elastomer subclavian catheters. J Parenter Enteral Nutr 1982; 6: 61–63.

    Article  CAS  Google Scholar 

  7. Bozzetti F, Scarpa D, Terno G et al. Subclavian venous thrombosis due to indwelling catheters: a prospective study on 52 patients. J Parenter Enteral Nutr 1983; 7: 560–562.

    Article  CAS  Google Scholar 

  8. Haire WD, Lieberman RP, Edney J et al. Hickman catheter-induced thoracic vein thrombosis. Frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990; 66: 900–908.

    Article  CAS  Google Scholar 

  9. Conlan MG, Haire WD, Lieberman RP et al. Catheter-related thrombosis in patients with refractory lymphoma undergoing autologous stem cell transplantation. Bone Marrow Transplant 1991; 7: 235–240.

    CAS  Google Scholar 

  10. Boraks P, Scale J, Price J et al. Prevention of central venous catheter-associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998; 101: 483–486.

    Article  CAS  Google Scholar 

  11. Emmerich J, Rosendaal FR, Cattaneo M et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism- pooled analysis of 8 case–control studies including 2310 cases and 3204 controls. Thromb Haemost 2001; 86: 809–816.

    Article  CAS  Google Scholar 

  12. Fijnheer R, Paijmans B, Verdonck LF et al. Factor V Leiden in central venous catheter-associated thrombosis. Br J Haematol 2002; 118: 267–270.

    Article  CAS  Google Scholar 

  13. Bertina RM, Koeleman BP, Koster T et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64–67.

    Article  CAS  Google Scholar 

  14. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM . A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698–3703.

    CAS  PubMed  Google Scholar 

  15. Martinelli I, Mannucci PM, De Stefano V et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92: 2353–2358.

    CAS  PubMed  Google Scholar 

  16. Seldinger S . Catheter replacement of the needle in percutaneous arteriography: a new technique. Acta Radiol 1953; 39: 368–376.

    Article  CAS  Google Scholar 

  17. Koksoy C, Kuzu A, Kutlay J et al. The diagnostic value of colour Doppler ultrasound in central venous catheter related thrombosis. Clin Radiol 1995; 50: 687–689.

    Article  CAS  Google Scholar 

  18. Prandoni P, Polistena P, Bernardi E et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57–62.

    Article  CAS  Google Scholar 

  19. Patel MC, Berman LH, Moss HA et al. Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 1999; 211: 579–583.

    Article  CAS  Google Scholar 

  20. Ratcliffe M, Broadfoot C, Davidson M et al. Thrombosis, markers of thrombotic risk, indwelling of central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease. Clin Lab Haematol 1999; 21: 353–357.

    Article  CAS  Google Scholar 

  21. Riordan M, Weiden PL . Factor V leiden mutations does not account for central venous catheter-related thrombosis. Am J Hematol 1998; 58: 150–152.

    Article  CAS  Google Scholar 

  22. van Rooden CJ, Rosendaal FR, Meinders AE et al. The contribution of factor V Leiden and prothrombin G20210A mutation to the risk of central venous catheter-related thrombosis. Haematologica 2004; 89: 201–206.

    CAS  PubMed  Google Scholar 

  23. Bern MM, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423–428.

    Article  CAS  Google Scholar 

  24. Monreal M, Alastrue A, Rull M et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices: prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251–253.

    CAS  Google Scholar 

  25. Abdelkefi A, Ben Othman T, Kammoun L et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. Throm Haemost 2004; 92: 654–661.

    Article  CAS  Google Scholar 

  26. van Rooden CJ, Monraats PS, Kettenis I et al. Low physician compliance of prescribing anticoagulant prophylaxis in patients with solid tumor or haematological malignancies and central vein catheters. J Thromb Hemost 2003; 1: 1842–1843.

    Article  CAS  Google Scholar 

  27. Carr KM, Rabinowitz I . Physician compliance with warfarin prophylaxis for central venous catheters in patients with solid tumors. J Clin Oncol 2000; 18: 3665–3667.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre National de Greffe de Moelle Osseuse, Tunis, Tunisia

    A Abdelkefi, L Torjman, S Ladeb, T Ben Othman, A Lakhal, A Ben Hassen & A Ben Abdeladhim

  2. Hôpital La Rabta, Tunis, Tunisia

    N Ben Romdhane & A Kriaa

  3. Institut Kassab, Tunis, Tunisia

    M Chelli & F Ladeb

  4. Hôpital Charles Nicolle, Tunis, Tunisia

    S Guermazi

Authors
  1. A Abdelkefi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N Ben Romdhane
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Kriaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Chelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Torjman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S Ladeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. T Ben Othman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A Lakhal
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. S Guermazi
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. A Ben Hassen
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. F Ladeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Ben Abdeladhim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Abdelkefi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdelkefi, A., Ben Romdhane, N., Kriaa, A. et al. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients. Bone Marrow Transplant 36, 885–889 (2005). https://doi.org/10.1038/sj.bmt.1705156

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705156

Keywords

This article is cited by

Search

Advanced search

Quick links